GOSS
Gossamer Bio, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$2.46
$-0.21
(-7.87%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $569.38M | EPS (ttm) | $-0.69 | Current Price | $2.46 |
| Enterprise Value | $640.64M | Forward EPS | $-0.58 | Previous Close | $2.67 |
| P/E Ratio | - | ROA | -34.25% | 52W High | $3.87 |
| Forward P/E | -4.25 | ROE | - | 52W Low | $0.76 |
| PEG Ratio | - | Gross Margin | 100.00% | 50 Day Avg | $3.02 |
| P/S Ratio | 12.93 | Operating Margin | -313.21% | 200 Day Avg | $2.19 |
| P/B Ratio | -6.91 | Profit Margin | - | Volume | 6.85M |
| EV/EBITDA | -4.18 | Current Ratio | 3.28 | Avg Volume | 4.17M |
| EV/Sales | 14.54 | Quick Ratio | 3.06 | Beta | 1.95 |
| Employees | 144.00 | Debt/Equity | - | Shares Outstanding | 231.46M |
| Sector | Healthcare | Total Debt | $202.88M | Float Shares | 187.91M |
| Industry | Biotechnology | Total Cash | $180.22M | Short Float | 11.59% |
| Optionable | Yes | Cash/Share | $0.78 | Short Ratio | 4.92 |
| Dividend Yield | - | Book Value/Share | $-0.36 | % Held by Insiders | 4.16% |
| Target Price | $9.43 | Revenue (TTM) | $44.05M | % Held by Institutions | 78.50% |